Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Cancer Therapy: Preclinical

Dual Blockade of HER2 in HER2-Overexpressing Tumor Cells Does Not Completely Eliminate HER3 Function

Joan T. Garrett, Cammie R. Sutton, María Gabriela Kuba, Rebecca S. Cook and Carlos L. Arteaga
Joan T. Garrett
Authors' Affiliations: Departments of Medicine, Pathology, and Cancer Biology, Breast Cancer Research Program, and Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cammie R. Sutton
Authors' Affiliations: Departments of Medicine, Pathology, and Cancer Biology, Breast Cancer Research Program, and Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Gabriela Kuba
Authors' Affiliations: Departments of Medicine, Pathology, and Cancer Biology, Breast Cancer Research Program, and Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca S. Cook
Authors' Affiliations: Departments of Medicine, Pathology, and Cancer Biology, Breast Cancer Research Program, and Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, TennesseeAuthors' Affiliations: Departments of Medicine, Pathology, and Cancer Biology, Breast Cancer Research Program, and Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos L. Arteaga
Authors' Affiliations: Departments of Medicine, Pathology, and Cancer Biology, Breast Cancer Research Program, and Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, TennesseeAuthors' Affiliations: Departments of Medicine, Pathology, and Cancer Biology, Breast Cancer Research Program, and Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, TennesseeAuthors' Affiliations: Departments of Medicine, Pathology, and Cancer Biology, Breast Cancer Research Program, and Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, TennesseeAuthors' Affiliations: Departments of Medicine, Pathology, and Cancer Biology, Breast Cancer Research Program, and Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-12-2024
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1158/1078-0432.CCR-12-2024
PubMed 
23224399

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Received June 19, 2012
  • Revision received November 12, 2012
  • Accepted November 20, 2012
  • Published first December 5, 2012.

Article Versions

  • Previous version (December 5, 2012 - 06:28).
  • You are currently viewing a Previous version of this article (January 11, 2013 - 09:30).
  • View the most recent version of this article
Copyright & Usage 
©2012 American Association for Cancer Research.

Author Information

  1. Joan T. Garrett1,
  2. Cammie R. Sutton1,
  3. María Gabriela Kuba2,
  4. Rebecca S. Cook3,4, and
  5. Carlos L. Arteaga1,3,4,5
  1. Authors' Affiliations: Departments of 1Medicine, 2Pathology, and 3Cancer Biology, 4Breast Cancer Research Program, and 5Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee
  1. Corresponding Author:
    Carlos L. Arteaga, Division of Oncology/VUMC, Vanderbilt University, 2220 Pierce Avenue, 777 PRB, Nashville, TN 37232. Phone: 615-936-3524; Fax: 615-936-1790; E-mail: carlos.arteaga{at}vanderbilt.edu

Next
Back to top

Published OnlineFirst January 11, 2013
doi: 10.1158/1078-0432.CCR-12-2024

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dual Blockade of HER2 in HER2-Overexpressing Tumor Cells Does Not Completely Eliminate HER3 Function
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
Citation Tools
Dual Blockade of HER2 in HER2-Overexpressing Tumor Cells Does Not Completely Eliminate HER3 Function
Joan T. Garrett, Cammie R. Sutton, María Gabriela Kuba, Rebecca S. Cook and Carlos L. Arteaga
Clin Cancer Res January 11 2013 DOI: 10.1158/1078-0432.CCR-12-2024

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dual Blockade of HER2 in HER2-Overexpressing Tumor Cells Does Not Completely Eliminate HER3 Function
Joan T. Garrett, Cammie R. Sutton, María Gabriela Kuba, Rebecca S. Cook and Carlos L. Arteaga
Clin Cancer Res January 11 2013 DOI: 10.1158/1078-0432.CCR-12-2024
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Enhanced Delivery of SN38-TOA NPs in NBs
  • Radiotherapy with IDO1/PD-1 Blockade Treats Advanced GBM
  • TCRs against MCV T-antigens
Show more Cancer Therapy: Preclinical
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement